BIRC2 and lip and oral cavity carcinoma: Here, we validate the amplifications of 11q13.3 and 11q22.1-q22.2 in OSCC and evaluated the expression of BIRC2 and BIRC3 with respect to lymph node metastasis and poor survival in oral cancer patients.